Introduction
Papillomaviruses (PV) are small DNA viruses that infect various epithelial tissues. Some animal PVs, including BPV-1, also induce ®bropapillomas. Speci®c types (`high-risk') of human papillomaviruses (HPV) infect the anogenital tract and are strongly associated with the development of cervical carcinoma (for review, see zur Hausen (1996) ). Because of its ability to transform and replicate its genome in established murine cell lines, BPV-1 has served as the prototype for studies of the molecular biology of the papillomaviruses (for review, see Howley (1996) ).
BPV-1 encodes two transforming proteins, E5 and E6. Each of these proteins is sucient to induce anchorage-independent growth and focus formation of C127 cells (DiMaio et al., 1986; Dvoretzky et al., 1980; Gro and Lancaster, 1986; Lowy et al., 1980; Schiller et al., 1984 Schiller et al., , 1986 Schlegel et al., 1986) . BPV-1 E6-transformed C127 cells form tumors in nude mice (Schiller et al., 1984) . The BPV-1 E6 oncogene product is a 137-amino acid protein with two putative zinc ®nger motifs that are conserved among all papillomavirus E6 proteins. The mechanism of BPV-1 E6-induced cell transformation is not known. Although E6 proteins from high-risk HPVs bind and promote the degradation of the tumor suppressor protein p53, BPV-1 E6 does not (Werness et al., 1990) . We recently identi®ed E6BP (or ERC-55) as a cellular binding protein for both high-risk HPV and BPV-1 E6 proteins (Chen et al., 1995) . The transforming activity of a set of previously characterized BPV-1 E6 mutants correlated with their E6BP-binding ability, suggesting that this interaction may play an important role in BPV-1 E6 mediated transformation. BPV-1 E6 also eciently binds E6-AP (Chen et al., 1995) , the cellular protein through which HPV-16 E6 stimulates ubiquitination and degradation of p53. However, a candidate cellular target for a potential BPV-1 E6/E6-AP complex has not been identi®ed. More recently, an interaction between the BPV-1 E6 protein and the focal adhesion associated protein paxillin as well as the trans-Golgi network-speci®c clathrin adaptor (AP-1) complex has been described (Tong and Howley, 1997; Tong et al., 1998; Vande Pol et al., 1997) , although the biological relevance of these interactions remains to be established.
BPV-1 E6 stimulates transcription when targeted to a promoter (Lamberti et al., 1990) , although cellular promoters responsive to BPV-1 E6 have not been identi®ed. Mutational analysis indicated that the transcriptional activation function of BPV-1 E6 is not sucient for cell transformation (Chen et al., 1997; Ned et al., 1997) . Furthermore, a mutant with greatly reduced transcriptional activation activity yet competent for transformation has been identi®ed, raising the possibility that transformation by BPV-1 E6 is independent of its transcriptional activation function (Ned et al., 1997) .
Many viral as well as cellular oncogenes have been shown to be involved in modulation of apoptosis (Shen and Shenk, 1995) , a genetically programmed process of self destruction (Kerr and Harmon, 1992) . Apoptosis represents an integral component of normal cellular maintenance and serves to eliminate aberrantly proliferating (due to oncogene activation) or virally infected cells that may threaten survival of the organism. In the case of virally infected cells, this early cell death inhibits viral replication and production of progency virus (Hardwick, 1997) . Many lytic animal viruses have evolved speci®c gene products that interfere with premature death allowing production of high levels of progeny virus (for review, see Shen and Shenk (1995); Teodoro and Branton, (1997) ). Viral anti-apoptotic function, coupled with the growth promoting functions, can contribute to uncontrolled growth and oncogenesis.
The tumor suppressor protein p53 plays an important role in the induction of apoptosis, although the mechanism of p53-induced apoptosis is unresolved (reviewed in Levine (1997) ). Since E6 proteins from high-risk HPVs bind and promote the degradation of p53, it is intuitive to propose that they would suppress apoptosis. Multiple diverse studies have addressed the role of high-risk HPV E6 in apoptosis, and both proand anti-apoptosis activities of E6 have been reported (Fan et al., 1995; Hawkins et al., 1996; Griep, 1994, 1995; Puthenveetil et al., 1996; Steller et al., 1996; Thomas et al., 1996; Tsang et al., 1995; Wahl et al., 1996; Xu et al., 1995; Yu et al., 1997) . The apparent inconsistency in determining the eect of E6 on apoptosis could be due to experimental conditions. Some of the apoptosis modulatory eects of E6 were proposed to represent a p53-independent function Pan and Griep, 1995; Steller et al., 1996) . It is clear that high-risk E6 possesses p53-independent transforming potential. The eect of BPV-1 E6 on cell apoptosis has not been reported.
TNF is a 17-kDa in¯ammatory cytokine that mediates a variety of immune and in¯ammatory reactions (Tracey and Cerami, 1993) . Some tumor cell lines are spontaneously sensitive to TNF, but most cell lines are resistant (Carswell et al., 1975; Sugarman et al., 1985) . The majority of the latter cells can be sensitized to TNF by inhibitors of transcription or translation (Kull and Cuatrecasas, 1981; Ostrove and Giord, 1979) . Infection with some virus types such as adenovirus also induces susceptibility to the cytotoxic eect of TNF (Chen et al., 1987; Deurksen-Hughes et al., 1989) . C127 cells, which originate from an RIII mouse mammary tumor, are sensitive to TNF in the presence of metabolic inhibitors or some viral proteins (Bergovist et al., 1997; Carswell et al., 1975; Gooding et al., 1991) . Moreover, C127 cells are protected from TNF cytotoxicity by viral proteins such as adenovirus E3 and polyomavirus small T antigen (Bergovist et al., 1997; Gooding et al., 1991) . Recently, BPV-1-transformed C127 cells were shown to have increased TNF sensitivity (Bergovist et al., 1997) .
In this study, we describe the establishment of a BPV-1 E6 expressing cell line and the investigation of the eect of BPV-1 E6 on sensitization to TNF. Our results indicate that expression of BPV-1 E6 sensitizes cells to TNF-induced apoptosis. We also provide evidence that BPV-1 E6 induced apoptosis can occur in the absence of p53.
Results

Establishment of a BPV-1 E6-transformed cell line
To investigate the eect of BPV-1 E6 expression on TNF sensitivity, a cell line that expresses BPV-1 E6, named PBE6, was established. For this purpose, C127 cells were infected with amphotrophic retroviruses containing BPV-1 E6. After puromycin selection, populations of infected cells were pooled and used for subsequent experiments. To avoid the possibility of chromosomal instability due to the expression of BPV-1 E6, all experiments described here were performed using cells within 12 passages. C127 cells infectd with retroviruses containing the vector Babe Puro (PURO) were also selected and served as the control. Similarly, C127 cells expressing BPV-1 E6 mutants 359 (PB359) and 471 (PB471) were also established. These mutants are defective for C127 cell transformation, transcriptional activation, and interaction with E6BP or E6-AP (Chen et al., 1995 (Chen et al., , 1997 Vousden et al., 1989) .
Morphologically, PBE6 cells at low density exhibited altered morphology and became spindle-shaped ( Figure  1a ). In contrast, PURO cells remained¯at and were morphologically indistinguishable from that of parental C127 cells. Within 24 h of con¯uence, PBE6 cells piled up and became highly spindle shaped, indicating a loss of contact inhibition seen in focus formation assays with BPV-1 E6 (Figure 1b) . No foci were found in the control Puro cells for up to 3 weeks. PBE6 grew to a higher density than PURO cells. A cell line that expresses functional BPV-1 E6 at physiological levels has thus been established. PB359 cells and PB471 cells exhibited similar morphology as PURO cells (data not shown).
To con®rm the expression of BPV-1 E6 in PBE6 cells, we performed an immunoprecipitation experiment using BPV-1 E6 speci®c antisera. BPV-1 E6 protein was present at a very low level (data not shown) in agreement with previous observations (Androphy et al., 1985) . This indicates that in the PBE6 cells, BPV-1 E6 protein level was in the physiologic range and overexpression of the protein did not occur.
Expression of BPV-1 E6 sensitizes C127 cells to cytolysis induced by TNF
The E6 expressing cells were treated with various concentrations of murine TNF and cell viability was determined quantitatively by analysis of MTT conversion (Hansen et al., 1989) . As shown in Figure 2a , PBE6 cells were much more susceptible to TNF treatment. While TNF induced 8% of the PURO cells to undergo cytolysis at a concentration of 10 ng/ml, 33% of PBE6 cells exhibited cytolysis. The E6-mediated cell susceptibility to TNF-induced cytolysis required some of the wild-type E6 activities, as PB359 and PB471 cells did not display increased cytolysis as compared with PURO cells (data not shown). A two-color¯uorescence cell viability assay was also performed to visualize the TNF-induced cytolysis ( Figure 2b ). In this assay two¯uorogenic dyes are used to simultaneously visualize viable and dead cells. Green¯uorescent calcein is retained only in viable cells, and red¯uorescent ethidium homodimer only permeates damaged membranes of dying cells. Therefore, viable cells appear green, dead cells appear red, and dying cells appear yellow (red + green). As in the MTT assay, the eect of BPV-1 E6 was apparent: increased susceptibility to TNF-induced cytolysis as revealed by an increase in the numbers of red and yellow cells. Our results indicate that expression of BPV-1 E6 sensitizes cells to TNFinduced cytolysis. Does E6 expression account for all the BPV-1-associated TNF sensitivity? To address this question, we compared the TNF sensitivity of PBE6 cells with that of ID13 cells. ID13 is a BPV-1 transformed C127 cell line commonly employed for BPV-1 replication studies These results demonstrate that not all BPV-1 transformed C127 cell lines have increased sensitivity to TNF, suggesting that some other genes from BPV-1 may protect cells from E6-mediated sensitivity to TNF. We also compared the TNF sensitivity of PBE6 cells with CNm41 cells, a polyomavirus middle T antigen (MT)-expressing C127 cell line (Bergovist et al., 1997) . Unlike PBE6 cells, treatment of CNm41 cells with TNF did not lead to increased cell death (data not shown). However, in the presence of actinomycin D, CNm41 cells exhibited modest increase in susceptibility to TNF. The eect of E6 was much stronger (Figure 3 ).
PBE6 cells undergo apoptosis after TNF treatment
TNF kills most cell types by apoptosis rather than necrosis (Laster et al., 1988) . Although the MTT conversion and the two-color¯uorescence cell viability assays provide a measure of cell survival and cytotoxicity, they do not dierentiate between cells dying of necrosis or apoptosis. There are currently many assays available for detecting apoptosis. To examine if the cytolysis of PBE6 cells after TNF treatment is apoptotic, we performed the Cell Death Detection ELISAplus assay which provides a qualitative and quantitative determination of cytoplasmic histone-associated-DNA-fragments resulting from DNA degradation that occurs speci®cally in apoptotic cells. During the process of apoptosis, a number of cellular proteases and endonucleases are activated and cellular DNA is degraded to characteristic nucleosomesized fragments. As Figure 4 shows, treatment of PBE6 cells with TNF for 24 h resulted in speci®c enrichment of mono-and oligonucleosomes released into the cytoplasm. More than threefold enrichment of nucleosomes in the cytoplasm was observed in PBE6 cells as compared with PURO cells. These results demonstrate that PBE6 cells undergo apoptosis after TNF treatment.
We also analysed the TNF-induced DNA fragmentation in PBE6 cells by¯ow cytometry analysis. DNA samples from cells treated with TNF were stained with 
BPV-1 E6-induced apoptosis is independent of p53
The tumor suppressor protein p53 plays an important role in the induction of apoptosis (reviewed in Levine (1997) The standard deviations of the data from PBE6 are 10.6% (10 ng/ml), 16.6% (33 ng/ml), and 16.4% (100 ng/ ml), respectively. Those from PURO are 5.8% (10 ng/ml) 13.3% (33 ng/ml), and 16.6% (100 ng/ml), respectively. (b) Two-Color Fluorescence Cell Viability Assay. Subcon¯uent proliferating cells were treated with 10 ng/ml of TNF for 48 h. Viable cells (green), dying cells (yellow), and dead cells (red) were detected by the LIVE/DEAD Euko-Light Viability/Cytotoxicity kit. The apoptotic cells in TNF-treated PBE6 cells are under-represented as some were washed away during treatment apoptosis is p53-dependent (Shen and Shenk, 1995) . For example, p53-dependent apoptosis induction by the adenovirus E1A protein has been described (Debbas and White, 1993; Lowe and Ruley, 1993) . Although BPV-1 E6 does not bind p53 in vitro or promote its degradation in vivo, it is intriguing to test the requirement of p53 for BPV E6-mediated sensitization of cells to TNF-induced apoptosis. C127 cells are reported to contain wild-type p53 (Murphy et al., 1996) . To assess the role of p53 in BPV-1 E6-induced apoptosis, a p53-null cell line expressing BPV-1 E6 (PBE6-10.1) was established. This was achieved by infection of the p53-null mouse cell line 10.1 with amphotrophic retroviruses containing BPV-1 E6. After puromycin selection, populations of infected cells were pooled. Similarly, a control p53-null cell line infected by the retrovirus vector (PURO-10.1) was also selected. The sensitization of resulting cell lines to TNF treatment was then analysed. As shown in Figure 5 , increased cytolysis was observed in cells expressing PBV-1 E6 as compared to the control cells. Speci®cally, TNF induced 35% cytolysis of the PBE6-10.1 cell at a concentration of 100 pg/ml, while PURO-10.1 only exhibited 6% cytolysis. Notably, the sensitivity of p53-null mouse cells to TNF is much higher than that of C127 cells, as similar cytolysis can be achieved with much lower concentrations of TNF for 10.1-derived cells. These data indicate BPV-1 E6-mediated sensitiza- tion of cells to TNF-induced cytolysis can occur in the absence of p53, although it does not rule out the possibility that some of the activities seen in C127 cells involve p53.
Sensitization of PBE6 cells to TNF-induced apoptosis is accompanied by increased release of arachidonic acid
The TNF-induced lysis of susceptible cells is accompanied by the release of arachidonic acid (AA) into the culture media (Hayakawa et al., 1993) . The release of AA also accompanies the lysis of cells rendered sensitive to TNF by inhibitors of transcription or translation and some viral proteins (Bergovist et al., 1997; Krajcsi et al., 1996; Thorne et al., 1996; VoelkelJohnson et al., 1996) . Previous work has demonstrated that activation of the 85 kDa cytosolic phospholipase A 2 (cPLA 2 ) is required for TNF cytolysis (Hayakawa et al., 1993; Hoeck et al., 1993; Voelkel-Johnson et al., 1996) . These studies have also revealed that the activity of cPLA 2 is necessary for cell death. Phospholipase A 2 speci®cally cleaves AA from the sn2 position of membrane phospholipid, which is thereby released from the cells (Clark et al., 1991; Durstin et al., 1994; Hoeck et al., 1993) . Measurement of 3 H-labeled arachidonic acid ( 3 H-AA) released from TNF treated cells is threfore a measure of cPLA 2 activity. To determine if cPLA 2 activation is important in the response of E6-expressing cells to TNF, AA release was measured in this assay. After labeling of cells and treatment with TNF, release of 3 H-AA into the culture media was analysed. As shown in Figure 6 , TNF caused a modest increase of cPLA 2 activity on PURO cells. Importantly, PBE6 cells consistently showed a greater increase in released arachidonic acid. This correlated well with increased cytotoxicity as measured by other assays.
Discussion
The BPV-1 E6 oncoprotein has been shown to induce tumorigenic transformation of murine C127 cells and stimulate transcription when targeted to a promoter. In this study, we present evidence that expression of BPV-1 E6 sensitizes murine C127 cells to TNF-induced apoptosis. We also provide evidence that BPV-1 E6-mediated sensitization of cells to TNF-induced apoptosis can occur in the absence of p53. In addition, we show that induction of apoptosis by TNF in PBE6 cells is accompanied by increased release of arachidonic acid, indicating that phospholipase A 2 was activated. Sensitization of cells to TNF-induced apoptosis is a novel biological activity identi®ed for BPV-1 E6.
What is the biological relevance of sensitizing cells to TNF-induced apoptosis by BPV-1 E6? Apoptosis may serve to eliminate virally infected cells that will threaten survival of the organism. Many viruses stimulate cell division because of the need to replicate their genome. Inappropriate activation of cell cycle progression by a viral protein or external agent results in this protective response by the cell. This may explain why cancer is a rare event. In the case of infection by potentially oncogenic viruses, apoptosis would bene®t the host and avoid accumulation of tumor cells. Induction of apoptosis by BPV-1 E6 may be important in restraining the emergence of neoplasia or removing a population of cells that are transformed. This may both restrain inappropriate cell growth and maintain normal tissue dierentiation that is necessary for viral replication.
In addition to apoptosis-promoting genes, viruses have evolved gene products that exhibit anti-apoptotic activity (for review see Shen and Shenk (1995) ; Teodoro and Branton (1997) ). For example, adenovirus E1A-induced apoptosis can be counteracted by the adenovirus E1B 19 kDa and E1B 55 kDa proteins (Debbas and White, 1993; Rao et al., 1992) . Similar to adenovirus E1A/E1B mediated apoptosis regulation, HPV 16 E6 inhibited E7-induced apoptosis in the developing ocular lens of transgenic mice (Pan and Griep, 1995) . In our experiments TNF-induced apoptosis was similar in the BPV-1-transformed ID13 and parental C127 cell lines and substantially less than the E6 expressing cells. These observations suggest another BPV-1 gene may protect ID13 cells from E6-mediated susceptibility to TNF-induced apoptosis. The reason for increased TNF sensitivity in another BPV transformed cell line, wh.2, in comparison to untransformed C127 cells, is not clear (Bergovist et al., 1997) .
The ability of E6 to induce cell transformation may directly correlate with enhanced apoptosis. While the non-transforming mutants 471 and 359 did not induce apoptosis in C127 cells, the connection between transforming potential and stimulation of apoptosis requires more extensive analyses. For some oncogenes, the ability to induce a growth stimulatory signal was separable from the capability of promoting programmed cell death, and this may also occur with Figure 6 Increased release of arachidonic acid in BPV-1 E6-expressing cells treated with TNF. Subcon¯uent PBE6 or PURO cells were labeled overnight in complete media containing 0.33 mCi/ml [ 3 H]-AA. After extensive washing, the cells were incubated for 48 h in standard media or media containing 10 ng/ ml of TNF. The medium was collected and the amount of released arachidonic acid was determined in a liquid scintillation counter. Values represent a mean of seven experiments, each performed in duplicate. Error bars re¯ect the standard deviations of the mean
The E6 proteins from high-risk HPVs have been suggested to perform their oncogenic functions through inactivation of p53. There are also multiple reports that E6 has p53 independent transformation properties, implying that HPV E6 genes may uncouple cellular growth and apoptotic responses. However, both proand anti-apoptotic activities of E6 have been reported, and in some experimental systems, the apoptosis modulatory eects were thought to represent a p53-independent function of E6 (Fan et al., 1995; Hawkins et al., 1996; Griep 1994, 1995; Puthenveetil et al., 1996; Steller et al., 1996; Thomas et al., 1996; Tsang et al., 1995; Wahl et al., 1996; Xu et al., 1995; Yu et al., 1997) . Since BPV-1 E6 does not bind p53 in vitro or promote its degradation in vivo, it provides an excellent model to explore the p53-independent functions of E6. We present evidence that BPV-1 E6 mediated-sensitization of cells to TNF-induced apoptosis was observed in the absence of p53. No apparent dierence was observed between increased sensitivities of E6-expressing cells to TNF-induced apoptosis in the presence or absence of wild-type p53. These results strongly argue that BPV-1 E6 functions in a p53-independent fashion to modulate apoptosis. How BPV-1 E6 sensitizes cells to TNF is not clear. BPV-1 E6 may modulate the TNF receptors or amplify TNF-induced signals. Since BPV-1 E6 has transcriptional activation activity, it may up-regulate the expression of apoptosis related genes. The fact that BPV-1 E6 can sensitize cells to apoptosis in the presence of a transcription inhibitor suggests that no newly synthesized proteins are required for this process. Similar to the model proposed for c-Mycinduced apoptosis (Green, 1997) , BPV-1 E6 may repress an inhibitor(s) of TNF-induced apoptosis. This inhibitor may be short-lived, as actinomycin D can help to remove it. Further studies are needed to address these posibilities.
TNF elicits a wide spectrum of organismal and cellular responses, including fever, shock, tissue injury, tumor necrosis, cell proliferation, dierentiation, and apoptosis (Tracey and Cerami, 1993; Vandenabeele et al., 1995) . Exposure to TNF results in activation of at least three distinct eector functions, activation of JNK and NF-kB and induction of caspases (Liu et al., 1996) . There is considerable evidence that TNF cytolysis requires the activation of PLA 2 (for review see Krajcsi et al. (1996) . Mammalian cells generally contain multiple isoforms of PLA 2 that can be classsi®ed into three large groups, namely, secretory (sPLA 2 ), cytosolic (cPLA 2 ), and calcium-independent PLA 2s (Murakami et al., 1997) . Phospholipase A 2 speci®cally cleaves AA from the sn2 position of membrane phospholipid, which is thereby released from the cells (Clark et al., 1991; Durstin et al., 1994; Hoeck et al., 1993) . The TNF-induced lysis of susceptible cells is accompanied by the release of arachidonic acid (AA) into the culture media (Hayakawa et al., 1993) . We showed that TNFinduced apoptosis in PBE6 cells was accompanied by increased release of arachidonic acid, indicating that phospholipase A 2 was activated. Although it has been suggested that cPLA 2 is responsible for this eect (Hayakawa et al., 1993; Voelkel-Johnson et al., 1996) , the involvement of other forms of PLA 2 cannot be ruled out.
Recently, the rat homologue of E6BP (TCBP-49) has been identi®ed as a putative binding protein for the presynaptic snake venom toxin taipoxin (Dodds et al, 1995) . E6BP has 92% identity with TCBP-49. E6BP, also called ERC-55, is a highly structured calcium-binding protein with six EF-hand calciumbinding motifs (Weis et al., 1994) . The functions of E6BP are yet to be identi®ed. Because of its relatively low abundance, it is unlikely that E6BP acts as a calcium storage protein in the ER. Sequence comparison with other known proteins revealed that E6BP is similar to the family of calmodulins with 25% amino acid identity over the full length. Calmodulin is involved in the regulation of many cellular processes controlled by calcium-dependent signaling pathways (for review see James et al. (1995) ). By analogy with calmodulin and other characterized members of the EF-hand protein family, it is proposed that E6BP functions in regulating calcium-dependent activities in the ER by modulating the function of other proteins. The interaction between TCBP-49 and taipoxin provides a clue for function of E6BP. Taipoxin consists of a trimmer of a, b and g subunits, with each subunit having sequence homology to PLA 2 . The a subunit has phospholipase activity or toxicity (Karlsson, 1979) . It is possible that E6BP associates with and activates endogenous PLA 2 of mammalian origin. Interestingly, immediately after cell activation, cPLA 2 was shown to translocate from the cytosol to the perinuclear envelope and the ER (Schievella et al., 1995) , a location where E6BP was found. Moreover, the enzymatic activity of cPLA 2 is calcium dependent (Qiu et al. (1998) and references therein). It remains to be tested whether activation of PLA 2 by BPV-1 E6 involves E6BP. We are currently in the process of performing a comprehensive mutational analysis of BPV-1 E6 to assess its ability to sensitize cells to TNF-induced apoptosis and correlation to other activities of BPV-1 E6 such as transformation, transcriptional activation, and association with cellular proteins.
Materials and methods
Cells culture and establishment of stable BPV-1 E6 expressing cell lines
The 10.1 cells, a BALB/c mouse embryo ®broblast cell line, were maintained as described (Murphy et al., 1996) . C127 is a non-transformed clonal line derived from the mammary tissue of an RIII mouse (Lowy et al., 1978) . ID13 is an BPV-1 infected and transformed C127 cell line . CNm41 is a C127 derivative that expresses polyomavirus middle T antigen (Bergovist et al., 1997) . To establish stable BPV-1 E6 expressing cell lines, plasmids encoding wild-type or mutant BPV-1 E6 in pBabe Puro vector (Chen et al., 1997) were transfected into the amphotropic retrovirus packaging cell line PA317 (Miller and Buttimore, 1986) by calcium phosphate-mediated transfection. Transfected cells were selected for puromycin-resistance. Viruses were collected and titered on C127 cells to determine the puromycin-resistant colony forming units. For establishment of PBE6, PBE6-10.1 or control cell lines, C127 and 10.1 cells were infected with retroviruses. After puromycin selection, populations of infected cells were pooled and used for subsequent experiments. All experiments were performed using cells within 12 passages.
Metabolic labeling and immunoprecipitation
Proliferating cells were metabolically labeled for 12 h with 1 mCi of 35 S-cysteine (ICN Biomedicals, Irvine, CA, USA) per 10-cm dish in cysteine-free Dulbecco's minimum essential medium containing 5% dialyzed fetal calf serum. Cells were lysed at 48C in 1 ml of lysis buer (250 mM NaCl, 20 mM Tris-HCl (pH 7.4), 0.5% Nonidet P-40, 1 mM EDTA, 2 mM DTT, 0.1% nonfat dry milk, and 1 mM PMSF). Insoluble debris was pelleted at 10 000 g for 15 min and the supernatant incubated with anti-BPV-1 E6 antiserum (Androphy et al., 1985) and protein ASepharose beads. After washes with lysis buer, the beads were boiled in SDS sample buer and loaded onto SDSpolyacrylamide gels. The BPV-1 E6 band was analysed by a Molecular Imager (Bio-Rad).
Colorimetric MTT assay for cell survival Cells were seeded in 96-well plates at a density of 1610 3 cells per well. The following day, the media was changed to regular media (untreated cells) or media supplemented with various concentrations of mouse recombinant TNF (Sigma, St. Louis, MO, USA) as indicated in the text or Figure  legend (treated cells). In some experiments, TNF was added to the medium together with 2 mg/ml of actinomycin D. Following treatment with TNF, viable cells were measured using the quantitative colorimetric MTT assay kit (Chemicon International Inc., Temecula, CA, USA) according to the manufacturer's protocol. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is cleaved by living cells to yield a dark blue formazan product. Plates were analysed in an ELISA plate reader at 570 nM with a reference wavelength of 655 nM.
Two-color¯uorescence cell viability assay
Cells were seeded in 24-well plae at a density of 4610 3 cells per well. The following day, the media was changed to regular media (untreated cells) or media containing 10 ng/ ml TNF (treated cells) and incubated for 48 h. Following treatment with TNF the cells were washed once with PBS and incubated in PBS containing 10 mM ethidium homodimer and 2 mM calcein-AM (LIVE/DEAD Viability/ Cytotoxicity kit; Molecular Probes, Inc., Eugene, OR, USA) for 30 min. Cells were immediately viewed and photographed under a Nikon¯uorescence microscope.
Cell death detection ELISA Plus
Cells were seeded in 96 well plates at a density of 1610 3 cells per well. The following day, the media was changed to regular media (untreated cells) or media containing 10 ng/ ml TNF (treated cells) and incubated for 24 h. Of 200 ml extract collected from each well, 20 ml were used for analysis of nucleosomes in cytoplasmic fractions by Cell Death Detection ELISA plus kit (Boehringer Mannheim Corp., Indianapolis, IN, USA) according to the manufacturer's protocol. Enrichment factor represents the absorbency of treated cells divided by that of the corresponding untreated cells.
Arachidonic release assay
Cells were seeded in 96 well plates at a density of 1610 3 cells per well. After adhering to the plates, cells were labeled overnight in 200 ml complete media containing 0.33 mCi/ml [ 3 H]-AA ((5, 6, 8, 11, 12, 14, 15-3 H)-AA, 100 mCi/ml, NEN). The cells were then washed twice with PBS and incubated for 48 h in regular media or media containing 10 ng/ml of TNF. The medium was collected and the amount of released AA was determined by liquid scintillation counting.
